HAMILTON, Bermuda, July 19, 2022 (GLOBE NEWSWIRE) -- Altamira Therapeutics ("Altamira" or the “Company”) (NASDAQ:CYTO) a company dedicated to developing therapeutics that address important unmet medical needs, today announced the publication of a peer-reviewed article in the scientific journal Pharmaceutics titled, "The potential of cell-penetrating peptides for mRNA delivery to cancer cells," that covers an independently-funded study comparing various mRNA delivery platforms conducted by a Korean research group.
Read more at globenewswire.com